Cancer Testing Market in the US 2015-2019

2015-11-18
Price :
Published : Nov-2015
No. of Pages : 55

Cancer Testing Market in the US 2015-2019

Covering: Market size and forecast of the cancer testing market in the US and segmentation by technique, including genetic testing and conventional testing. The report discusses the major drivers influencing market growth and the challenges faced by the vendors and the market as a whole. The top vendors evaluated in the report are Abbott Diagnostics, Agilent Technologies, Beckman Coulter, and Roche Diagnostics.

Market outlook of the cancer testing market in the US

The market in the US is experiencing a lot of transformation in healthcare coverage, which have led to increased accessibility to healthcare, and thereby facilitating early diagnosis, preventive medicine, and personalized medicine. The increase in genetic testing for cancer by end-user segments such as hospitals, diagnostic laboratories, and academics and research institutes are expected to propel the growth of the market.

The predicts the cancer diagnostics market in the US to grow at a steady rate, posting a CAGR of over 9% during the forecast period.

Changes in healthcare system is one of the major drivers influencing the market growth. The number of the US citizens covered under healthcare insurance has increased tremendously and today about 19 million citizens in the US have insurance coverage. Also, big companies provide healthcare insurance policies to their employees, which will support the growth of the market.

Segmentation of the cancer testing market in the US by technique

  • Genetic testing
  • Conventional testing

The year 2014 saw the dominance of conventional testing segment, accounting for a market share of more than 76% and this segment is predicted to remain at the top through 2019.

Both genetic testing and conventional testing techniques are used for testing various types of cancer, including breast cancer, colorectal cancer, prostate cancer, and others.

Competitive landscape and key vendors

The cancer testing market in the US marks the existence of many small and medium sized vendors offering a diversified product portfolio. Large corporations are acquiring small and medium-sized manufacturers to enhance their product portfolio, which is adding to the competition.

Top vendors in this market are -

  • Abbott Diagnostics
  • Agilent Technologies
  • Beckman Coulter
  • Roche Diagnostics

Other prominent vendors included in this report are Affymetrix, Bio-Rad Laboratories, Cardinal Health, Cytyc, Fujirebio Diagnostics, Johnson & Johnson, Pathway Genomics, QIAGEN, Quest Diagnostics, Quidel, and Rosetta Genomics.

Growth drivers, challenges, and upcoming trends: Cancer testing

The market research analysts highlight the use of mass spectrometer, an extremely sophisticated instrumentation technology, which provide accurate results with infinitesimal amounts of material and does not even require specially purified samples.

This report provides a number of factors contributing to the adoption, limitations, and opportunities of the cancer testing market in the US. It also offers an analysis of each factor and an estimation of the extent to which the factors are likely to impact the overall market growth.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2019
  • What are the key factors driving the cancer testing market in the US
  • What are the key market trends impacting the growth of the cancer testing market in the US
  • What are the challenges to market growth
  • Who are the key vendors in the cancer testing market in the US
  • What are the market opportunities and threats faced by the vendors in the cancer testing market in the US
  • What are the key outcomes of the five forces analysis of the cancer testing market in the US
Filed in: Diagnostics
Publisher : Technavio
More Reports
Title Price Buy Now

Global Immunodiagnostics Market 2017-2021

The global immunodiagnostics market is in the moderate growth stage. The integration of mature clinical chemistry analyzers and restricted specificity and sensitivity of immunoassays have generated demand for integrated immunochemistry analyzers. The increasing volume of tests conducted due to rise in laboratory consolidation has driven the trend of automated analyzers globally. The analysts forecast global immunodiagnostics market to grow at a CAGR of 7.80% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global immunodiagnostics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of immunodiagnostics devices.. The market is divided into the foll......
$3500

Global HPV Testing Market 2016-2020

According to Centers for Disease Control and Prevention (CDC), human papillomavirus (HPV) refers to a group of more than 100 related viruses that commonly cause infections and do not have any symptoms. Among these, more than 40 types of HPVs cause highly contagious diseases that are transmitted through direct sexual contact, infecting both male and female genitals. The other types of HPV cause non-genital warts that are not sexually transmitted. Though most HPV infections are harmless and heal on their own, certain high-risk types of genital HPV can be persistent and cause cervical, penile, anal, vaginal, and oropharyngeal cancers. Many individuals, especially women, undergo regular HPV tests as a preventive measure. HPV tests help to detect the viral genetic material in a cell sample take......
$2500

Global Blood Stream Infection Testing Market 2016-2020

The presence of bacteria and fungi in blood leads to blood stream infections. Bacteria and fungi enter into the blood and cause severe complications and infections such as pneumonia, meningitis, sepsis and AIDS. Bloodstream infections are caused when bacteria enter the bloodstream; this may occur through a wound, injection, or through a surgical procedure. Symptoms of bacteremia may include fever, chills, malaise, nausea, diarrhea, shortness of breath, and vomiting. This analysts forecast the global blood stream infection testing market to grow at a CAGR of 7.75% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global blood stream infection testing market for 2016-2020. To calculate the market size, the repo......
$2500

Global Professional Diagnostics Market 2016-2020

The global professional diagnostics market is expected to grow at a high rate in the forecast period. Factors such as increasing aging population and rise in incidence and prevalence of chronic diseases and infections are driving the market. Cancer, tuberculosis, malaria, diabetes, and cardiovascular diseases are the main factors for the increasingly diagnosed population. In addition, increasing public awareness, rapid technological innovations, product approvals from regulatory authorities, and new product launches are expected to have a positive impact on the market over the next few years. This analyst forecast the global professional diagnostics market to grow at a CAGR of 6.76% during the period 2016-2020. Covered in this report This report covers the present scenario and the......
$2500

Global Point-of-Care Coagulation Testing Market 2016-2020

Coagulation testing measures the ability of blood to form a clot. Clotting is the process of the blood converting from a liquid into a gel form. Coagulation tests are carried out to detect clotting disorders such as hemorrhage and thrombosis. Many types of coagulation tests exist, including complete blood count, factor V assay, fibrinogen level, PT, platelet count, TT, and bleeding time. The analysts forecast global point-of-care coagulation testing market to grow at a CAGR of 6.53% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global point-of-care coagulation testing market for 2016-2020. A 360-degree view of the market, based on products, application, and technology segments, has been considered for ma......
$2500

Global Enteric Disease Testing Market 2016-2020

Enteric diseases are infections caused by ingested bacteria and viruses. Direct contact with contaminated feces or vomit is the secondary mode of contracting enteric ailments. Symptoms of enteric diseases include stomach pain, vomiting, diarrhea, nausea, weight loss, anorexia, and fever. Enteric diseases may lead to stunted growth, malnutrition, and impaired cognitive development. Enteric disease testing is performed on individuals using rapid tests, culture tests, enzyme immunoassay tests, and immunoassay tests. The analysts forecast global enteric disease testing market to grow at a CAGR of 8.9% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global enteric disease testing market for 2016-2020. To calcula......
$2500

Global Gonorrhea Diagnostics Market 2016-2020

Gonorrhea is a sexually transmitted disease that can affect both males and females. It is caused by the bacterium Neisseria gonorrhoeae. The bacterium grows in warm and moist areas of uterus, reproductive tract, fallopian tubes, and urethra. It can also grow and infect the throat, mouth, and anus. Women are more likely to contract this disease than men. Based on the Sexually Transmitted Disease Surveillance 2009 report, the Centers for Disease Control and Prevention (CDC) estimated that gonorrhea is the second most common communicable disease in the US. The analysts forecast global gonorrhea diagnostics market to grow at a CAGR of 9.25% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global gonorrhea diagn......
$2500

Global Transplant Diagnostics Market 2016-2020

Transplantation involves the transfer of cells, tissues, or organs from a donor to a recipient for restoring their function in cases of damage. Donor and recipient cells, tissues, and organs should match or be compatible, otherwise it can lead to transplant rejection. Human leukocyte antigens (HLAs) are present on the surface of the cells that regulate body recognition and reject foreign tissue transplants. In humans, major histocompatibility complex controlled by the genes located on chromosome 6 is responsible for ensuring compatibility between donors and recipients. The analysts forecast global transplant diagnostics market to grow at a CAGR of 6.63% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global......
$2500

IVD Market in Europe 2016-2020

IVD tests help diagnose, monitor, and assess medical conditions, diseases, and infections in a controlled environment. These tests help in early diagnosis of diseases by enhancing control on test procedures and provide accurate results, leading to quality treatment and shorter hospital stays. They are also minimally invasive and help in lowering treatment costs. Manufacturers develop reagents, analytical instruments such as automated analyzers, and accessory products including software to measure the quality and parameters of samples. The analysts forecast IVD market in Europe to grow at a CAGR of 4.78% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the IVD market in Europe for 2016-2020. To calculate the mar......
$2500

Global Rapid Diagnostics Market 2016-2020

Rapid diagnostic tests are diagnostic assays designed for low-resource settings that provide faster results. These can be carried out either at a patient's bedside or in a clinical setting. These devices are simple to operate and read, have a low cost, and are specific, sensitive, and stable at extreme temperatures. They also provide quick results. Rapid diagnostics is the fastest-growing segment in in vitro diagnostics (IVD). Rapid diagnostic tests include agglutination, lateral flow, flow through, solid phase, and nucleic-acid amplification tests. Diagnostic devices are used to detect and measure blood glucose and coagulation levels, cardiac biomarkers, infectious diseases, hemoglobin concentration, five-part differential blood count, and pregnancy and fertility status. These tests can b......
$2500